Publications by authors named "Christopher Zito"

Claim this Profile
V
Vascular mimicry as a facilitator of melanoma brain metastasis.
Olivia K Provance, Victor O Oria, Thuy T Tran, Jasmine I Caulfield, Christopher R Zito

Cell Mol Life Sci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma.
Victor O Oria, Hongyi Zhang, Christopher R Zito, Chetan K Rane, Xian-Yong Ma

Cell Mol Life Sci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[C]Methionine and [C]PBR28 as PET Imaging Tracers to Differentiate Metastatic Tumor Recurrence or Radiation Necrosis.
Thuy T Tran, Jean-Dominique Gallezot, Lucia B Jilaveanu, Christopher Zito, Gabriela Turcu

Mol Imaging· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases.
Sarah A Weiss, Christopher Zito, Thuy Tran, Kazuki Heishima, Veronique Neumeister

J Neurooncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells.
Thuy T Tran, Chetan K Rane, Christopher R Zito, Sarah A Weiss, Shlomit Jessel

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PLEKHA5 regulates tumor growth in metastatic melanoma.
Hongyi Zhang, Huifang Zhu, Gang Deng, Christopher R Zito, Victor O Oria

Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors.
William Damsky, Lucia Jilaveanu, Noel Turner, Curtis Perry, Christopher Zito

J Immunother Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial.
Harriet M Kluger, Veronica Chiang, Amit Mahajan, Christopher R Zito, Mario Sznol

J Clin Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805.
Lucia B Jilaveanu, Maneka Puligandla, Sarah A Weiss, Xin Victoria Wang, Christopher Zito

Clin Cancer Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Studies Across Tumor Types, Its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors.
Harriet M Kluger, Christopher R Zito, Gabriela Turcu, Marina K Baine, Hongyi Zhang

Clin Cancer Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens.
Marina K Baine, Gabriela Turcu, Christopher R Zito, Adebowale J Adeniran, Robert L Camp

Oncotarget· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites.
Harriet M Kluger, Christopher R Zito, Meaghan L Barr, Marina K Baine, Veronica L S Chiang

Clin Cancer Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.
Lucia B Jilaveanu, Fabio Parisi, Meaghan L Barr, Christopher R Zito, William Cruz-Munoz

Clin Cancer Res· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of drug targets in patients treated with sorafenib, carboplatin and paclitaxel.
Lucia B Jilaveanu, Fengmin Zhao, Christopher R Zito, John M Kirkwood, Katherine L Nathanson

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma.
Saadia A Aziz, Joshua A Sznol, Laurence Albiges, Christopher Zito, Lucia B Jilaveanu

Cancer Cell Int· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cells.
Christopher R Zito, Lucia B Jilaveanu, Valsamo Anagnostou, David Rimm, Gerold Bepler

PLoS One· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for metastatic melanoma.
Christopher R Zito, Harriet M Kluger

J Cell Biochem· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro studies of dasatinib, its targets and predictors of sensitivity.
Lucia B Jilaveanu, Christopher R Zito, Saadia A Aziz, Ashok Chakraborty, Michael A Davies

Pigment Cell Melanoma Res· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vertical targeting of the phosphatidylinositol-3 kinase pathway as a strategy for treating melanoma.
Saadia A Aziz, Lucia B Jilaveanu, Christopher Zito, Robert L Camp, David L Rimm

Clin Cancer Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-Raf is associated with disease progression and cell proliferation in a subset of melanomas.
Lucia B Jilaveanu, Christopher R Zito, Saadia A Aziz, Patricia J Conrad, John C Schmitz

Clin Cancer Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphatidylinositol-3-kinase as a therapeutic target in melanoma.
Saadia A Aziz, Michael Davies, Elah Pick, Christopher Zito, Lucia Jilaveanu

Clin Cancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib.
Lucia Jilaveanu, Christopher Zito, Sandra J Lee, Katherine L Nathanson, Robert L Camp

Clin Cancer Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dimeric SecA is essential for protein translocation.
Lucia B Jilaveanu, Christopher R Zito, Donald Oliver

Proc Natl Acad Sci U S A· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of a conserved glutamate residue in the Escherichia coli SecA ATPase mechanism.
Christopher R Zito, Edwin Antony, John F Hunt, Donald B Oliver, Manju M Hingorani

J Biol Chem· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-stage binding of SecA to the bacterial translocon regulates ribosome-translocon interaction.
Christopher R Zito, Donald Oliver

J Biol Chem· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis